Teva Retains Inside Track To Market Generic Celebrex
Teva Pharmaceutical Industries Ltd. has kept exclusive rights to market its generic version of Pfizer Inc.'s arthritis drug Celebrex, as a West Virginia federal judge ruled Thursday that the U.S. Food...To view the full article, register now.
Already a subscriber? Click here to view full article